Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions. In ...

The role of combination therapy is explored for the treatment of COPD. December 14th 2022EP. 5: Implementing Inhaled Corticosteroids (ICS) into COPD Patient Treatment Regimen Inhaled ...

AstraZeneca’s new inhaler Bevespi Aerosphere (glycopyrronium/formoterol fumarate) has been approved in Europe, as a maintenance treatment for chronic obstructive ...

Medscape Medical News, August 08, 2023 Study Questions Use of Branded Inhalers for COPD Researchers said their analysis found that a generic product approved in 2019 was equally effective as the ...

The company also agreed to reduce the list price of some of its inhalers ... Tens of millions of Americans suffer from asthma and COPD and rely on inhalers to breathe — about 25 million ...

Inhaler misuse leading to inadequate medication delivery impacts a person's ability to manage symptoms of chronic obstructive ...

A further 500 were given the triple combination but in two inhalers. COPD is term used to describe a number of progressive lung diseases such as emphysema. The main cause is smoking, although the ...

COPD Over 30 million Americans have COPD, and most use some form of inhaled medicine New research suggests that the majority of COPD patients might be using their inhalers improperly, impeding ...

Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.